GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Return-on-Tangible-Asset

Hindustan Bio Sciences (BOM:532041) Return-on-Tangible-Asset : 8.37% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Hindustan Bio Sciences's annualized Net Income for the quarter that ended in Dec. 2023 was ₹2.76 Mil. Hindustan Bio Sciences's average total tangible assets for the quarter that ended in Dec. 2023 was ₹33.01 Mil. Therefore, Hindustan Bio Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 8.37%.

The historical rank and industry rank for Hindustan Bio Sciences's Return-on-Tangible-Asset or its related term are showing as below:

BOM:532041' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -47.5   Med: -13   Max: 4.53
Current: 4.53

During the past 13 years, Hindustan Bio Sciences's highest Return-on-Tangible-Asset was 4.53%. The lowest was -47.50%. And the median was -13.00%.

BOM:532041's Return-on-Tangible-Asset is ranked better than
61.74% of 1082 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs BOM:532041: 4.53

Hindustan Bio Sciences Return-on-Tangible-Asset Historical Data

The historical data trend for Hindustan Bio Sciences's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Return-on-Tangible-Asset Chart

Hindustan Bio Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.36 1.45 -20.78 -16.02 -1.29

Hindustan Bio Sciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.48 6.03 1.45 8.05 8.37

Competitive Comparison of Hindustan Bio Sciences's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Return-on-Tangible-Asset falls into.



Hindustan Bio Sciences Return-on-Tangible-Asset Calculation

Hindustan Bio Sciences's annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=-0.405/( (29.758+32.866)/ 2 )
=-0.405/31.312
=-1.29 %

Hindustan Bio Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=2.764/( (33.013+0)/ 1 )
=2.764/33.013
=8.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data.


Hindustan Bio Sciences  (BOM:532041) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Hindustan Bio Sciences Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines